EYES - Second Sight Medical reports two-year results of its Orion study

Second Sight Medical Products (EYES) gains 7% premarket after announcing two-year results of its Early Feasibility Study of the Orion Visual Cortical Prosthesis (Orion).The Study was paused due to the COVID-19 pandemic, but is now resumed and, is a six subject trial.All subjects are still enrolled in the Study and recent visual function and functional vision results continue to demonstrate that a majority of participants benefit from Orion.Five out of five of those tested at the two-year mark are able to locate a white square on a dark computer screen significantly better with the Orion System on than with it off.Four out of five of those tested at the two-year mark are able to better identify the direction of motion of a bar moving across a computer screen with the Orion System on.The Functional Low-Vision Observer Rated Assessment has only been performed with two subjects and both were rated as receiving mild

For further details see:

Second Sight Medical reports two-year results of its Orion study